INS and obesity due to melanocortin 4 receptor deficiency: In spite of all the beneficial effects of the combination treatments on glucose homeostasis, two important issues remained unclear, namely (i) how insulin sensitivity was affected by the treatments, and (ii) whether the beneficial effects could be demonstrated under the conditions of established obesity and insulin resistance in dietary obese mice, i.e., under the situation mimicking the status of human T2D patients.